Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

A may sustain damage between gut and

may carry a self-renewing damage signal between gut and ; briefly stopping their formation could end it. The hypothesis is rejected if the effect requires or a carries it after are removed.

Stage of verification

  1. Hypothesis published2026-09-30
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionWhole body

Ageing mechanism

Main connectionAltered intercellular communication

Direction

Kind of knowledge gap

No current scientific result answers this requirement.Void gap

A double ring marks the main placement where a group contains several values.

Lens
Radical chain reaction
Goal
Затухание взаимного усиления возрастных повреждений
Competing hypotheses
3
Published
2026-09-30
As a hypothesis
8 / 10Clarity of mechanism
6 / 10Few extra conditions
10 / 10Completeness of the answer
6 / 10Novelty of the idea
10 / 10Few new entities
8 / 10Decisive experiment
6 / 10Silver-bullet potential
4 / 10Support from research
Poster: Lipid oxidation sustains gut-vascular damage
PosterOpen the sheet full size2026-09-30

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Metabolism and energy

    Lipid peroxidation

    A process involving peroxide-chain propagation that can cause persistent cellular injury

    Where this hypothesis actsA self-sustaining damage loop between intestinal and in an ageing organism

    Hypotheses on this target 6
    Lipid peroxidationInhibition. Hypotheses on this target 44Activation. Hypotheses on this target 0Function preservation. Hypotheses on this target 0Supplementation. Hypotheses on this target 0Feedback restoration. Hypotheses on this target 0Direct measurement. Hypotheses on this target 0
    • Inhibition4
    • Activation
    • Function preservation
    • Supplementation
    • Feedback restoration
    • Direct measurement

    What is proposed

    Inhibition

    Briefly suppress lipid peroxide formation in one tissue component

    With whatNot stated in the record

    HowIndependent methods of suppressing iron-dependent oxidation; specific interventions are not stated

    Possible result

    Possible lasting interruption of the circulating damage chain and simultaneous barrier and recovery

    From the recordКраткое подавление образования липидных перекисей в одном звене может погасить циркулирующую цепь

  2. Lipid

    Oxidized lipid molecules bearing hydroperoxide groups

    Where this hypothesis actsThe returned fraction of medium transferred between intestinal and components

    Hypotheses on this target 1
    Lipid hydroperoxidesLower level. Hypotheses on this target 0Neutralisation. Hypotheses on this target 11Supplementation. Hypotheses on this target 0Composition restoration. Hypotheses on this target 0
    • Lower level
    • Neutralisation1
    • Supplementation
    • Composition restoration

    What is proposed

    Neutralisation

    Neutralize by selective chemical reduction

    With whatNot stated in the record

    HowSelectively reduce in the returned fraction; the reducing agent is not stated

    Possible result

    Expected disappearance of transferable damaging and lasting recovery after reconnection

    From the recordно прекращается после избирательного восстановления липидных гидроперекисей в возвращаемой фракции

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid AM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNTLipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxides
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstructionLipid peroxidation. Hypotheses on this target 6Lipid peroxidation
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Damage in the gut and blood vessels might keep renewing itself even after its original trigger disappears. The unexpected move is to propose that damaged fats carry injury between tissues, with each tissue producing the next batch, so a brief interruption could allow both to recover. This is a proposal generated by the pipeline, not a measured result.

The proposed mechanism, link by link
  1. The proposed loop begins with chemically damaged fats leaving one tissue inside fat-carrying or membrane particles.
  2. Those fats reach the other tissue and trigger iron-dependent chemical damage to its fats.
  3. The receiving tissue releases newly damaged fats that carry injury back to the starting tissue.
  4. Production that outpaces neutralization changes a fading injury into a self-sustaining loop.
  5. Brief suppression of damaging-fat production in one tissue lets the circulating disappear.
  6. After the interruption ends, ordinary injury remains below the level needed to restart the loop, allowing both tissues to recover.
A picture for it

Two facing microphones can keep a squeal going because each picks up and amplifies the other. Briefly disconnecting one can silence both.

Where the picture breaks: Reconnecting microphones can immediately restart the squeal. Lasting biological recovery requires the additional, unestablished claim that ordinary injury cannot restart the loop once its damaging material has disappeared.

  1. Master questionstep 01 of 04

    A treatment aimed at one shared cause of age-related damage might benefit several body systems at once.

    Rests on: The goal takes mutual reinforcement between aging processes as the reason to look for a shared point of intervention.

    Assumption

    The search assumes that mutually reinforcing damage contains a shared causal link whose treatment can benefit multiple systems; the supplied material does not establish such a treatment.

  2. Goal pillarstep 02 of 04

    Weakening the ways age-related injuries reinforce one another is the chosen route toward a broadly useful treatment.

    Rests on: The master question explicitly identifies mutual reinforcement and intervention at a shared causal link.

    Stated in the chain
  3. Gap questionstep 03 of 04

    Damage passing between tissues might have a boundary below which it stops sustaining itself, allowing lasting recovery after treatment of just one link. The work asks how breaking that loop could distinguish this possibility from simply reducing the total daily burden of injury.

    Rests on: The preceding goal supplies mutual reinforcement as the target; this stage turns it into a question about whether a temporary interruption can have a lasting effect.

    Stated in the chain
  4. Hypothesisstep 04 of 04

    , chemical damage to fats, is proposed to renew injury as damaged fats travel between the gut and blood vessels. , particles that package fats with proteins, or particles made from cell membranes would carry those fats into receiving cells, where would generate another damaging batch. A brief interruption would permit lasting recovery if ordinary injury cannot restart the extinguished loop.

    Rests on: The preceding question supplies the proposed self-sustaining loop and its interruption. The endpoint supplies a candidate mechanism: injury continues when fresh damaging material is produced faster than it is neutralized, and stops when that balance reverses.

    Stated in the chain

What is carried, and what is not. Two screened sources speak to local amplification and iron-dependent fat damage: the 2026 Frontiers in Immunology review S2 describes self-amplifying cell death associated with damaged fats in artery-wall deposits, but does not establish transfer between gut and blood vessels; the 2026 Frontiers in Immunology review S8 describes iron-driven fat damage and barrier breakdown in viral pneumonia, but does not establish regeneration of that across the proposed tissues. These support ingredients of the mechanism, while none of the supplied sources establishes the full sequence, its switching boundary, or lasting recovery after a brief interruption.S2S8

Where the reasoning is carried by something unstated · 1
  • Master question. The search assumes that mutually reinforcing damage contains a shared causal link whose treatment can benefit multiple systems; the supplied material does not establish such a treatment.
How a result here could mislead · 3
  • Damage after repeated transfers could come from surviving original material rather than fresh production in each receiving tissue. What closes it: The proposed , which uses distinguishable forms of atoms to track fats, must identify newly oxidized fats from each tissue. Damaging must also exceed the explainable by carried-over original material after dilution; fresh chemical products alone do not establish renewed damaging .
  • Loss of damage after chemical treatment of the transferred material could reflect removal of another active component or treatment carried into the receiving tissue. Conversely, continued damage could reflect incomplete removal of the intended target. What closes it: The , the separated portion of transferred material carrying the effect, must be . Selective neutralization of , fats bearing a reactive oxygen-containing chemical group, requires verification alongside controls for the treatment procedure and carryover. Separation from the rivals also requires checking cell division, changes in the relative survival of cell types, and mineral particles.
  • A spreading injury created by the test medium could be mistaken for a loop that sustains aging-related damage under ordinary conditions. What closes it: The proposal requires biologically justified concentrations and specifically flags artificial depletion of , a nutrient in the medium, as a way to create spreading cell death. Medium composition must be documented, and lasting recovery must be assessed after reconnection and after the intervention has ceased; the supplied material gives no numerical concentration limits or follow-up duration.

What would make this wrong. The proposed explanation would fail if repeated transfer produced no fresh damaging beyond residual original material, or if transmission persisted after verified selective neutralization of the proposed fat-based carrier. The endpoint also explicitly rejects the hypothesis if the effect requires changes in the relative survival of cell types or is carried by purified mineral particles after oxidized fats have been removed. Its lasting-recovery claim would fail if ordinary conditions restarted the loop after verified extinction and complete withdrawal of the intervention.

What it would change. If the mechanism held, one route toward a treatment benefiting several systems would be to extinguish a circulating source of renewed damage through a temporary intervention in one tissue. Work on the master question would then need to distinguish lasting interruption of that source from a temporary reduction in injury. Even a successful tissue-transfer test would not establish longer life or durable recovery in an aging organism; the supplied material specifies neither the test species nor a recovery timescale, and it does not define the claimed outcome called .

Sources read · 10

3 literature searches, 8 full texts, 2 abstract-only; 10 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1Background

Fatty Kidney Disease: From Renal Lipid Dysregulation to Fibrosis. · Biology · 2026

“Spatial lipidomic studies further reveal nephron-segment-specific lipid signatures and obesity-associated oxidized phospholipids linked to glomerular inflammation.”

Does not settle: This review does not establish a self-sustaining oxidation chain between gut and vascular tissue, transport by lipoproteins or membrane particles, iron-dependent re-initiation in recipient cells, a propagation threshold, or whether transient suppression in one tissue extinguishes such a circulating chain.

S2Partly answers it

OxLDL-induced ferroptosis and pyroptosis in atherosclerosis: a mini review. · Frontiers in immunology · 2026

“While ox-LDL can induce both apoptosis and ferroptosis in macrophages, ferroptosis uniquely propagates cell death through a self-amplifying cascade.”

Does not settle: Источник описывает самоподдерживающееся окислительное повреждение в атеросклеротической бляшке, но не устанавливает перенос между кишечником и сосудистой тканью, роль долгоживущих окисленных липидов в липопротеинах или мембранных частицах, порог запуска цепи, а также стойкое прекращение цепи после краткого подавления перекисного окисления липидов.

S3Partly answers it

High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature. · Arteriosclerosis, thrombosis, and vascular biology · 2012

“Studies with the 4F peptide suggest that the small intestine is a major tissue-regulating systemic inflammation in mouse models of atherosclerosis and may be an important site for determining the functionality of HDL.”

Does not settle: Обзор и приведённые в нём исследования на мышах не устанавливают самоподдерживающуюся цепь повреждения между кишечником и сосудистой тканью, её переносчик, железозависимое окисление в принимающих клетках, порог воспроизводства цепи или её устойчивое прекращение после краткого вмешательства.

S4Background

Beyond Cholesterol: Emerging Risk Factors in Atherosclerosis. · Journal of clinical medicine · 2025

“The gut microbiome, particularly metabolites like trimethylamine N-oxide (TMAO), has been implicated in vascular inflammation and plaque development, while beneficial short-chain fatty acids (SCFAs) demonstrate protective effects.”

Does not settle: Источник не устанавливает перенос окисленных липидов между кишечником и сосудистой тканью, самоподдерживающуюся цепь, железозависимое окисление в принимающих клетках, порог её запуска или эффект краткого подавления перекисного окисления липидов.

S5Partly answers itAbstract only

[Paraoxonase: The Universal Factor of Antioxidant Defense in Human Body]. · Vestnik Rossiiskoi akademii meditsinskikh nauk · 2017

“PON1 and PON3 proteins can be detected in plasma and reside in the high-density lipoprotein fraction and protect against oxidative stress by hydrolyzing certain oxidized lipids in lipoproteins, macrophages, and atherosclerotic lesions.”

Does not settle: Источник не устанавливает самоподдерживающуюся цепь между кишечником и сосудистой тканью, перенос окисленных липидов между этими звеньями, железозависимое окисление в принимающих клетках, порог воспроизводства цепи или эффект краткого подавления липидных перекисей.

S6Partly answers itAbstract only

Lipoproteins and Cardiovascular Redox Signaling: Role in Atherosclerosis and Coronary Disease. · Antioxidants & redox signaling · 2018

“Lipoproteins can stimulate vascular production of reactive oxygen species, which act as important signaling molecules in the cardiovascular system contributing to the pathophysiology of endothelial dysfunction, hypertension, and atherosclerosis.”

Does not settle: The abstract does not establish a self-sustaining gut-to-vascular lipid-oxidation chain, transfer by long-lived oxidized lipids, iron dependence in recipient cells, a reproduction-versus-termination threshold, or that transient suppression in one tissue extinguishes a circulating chain and permits simultaneous recovery.

S7Background

Mammalian cell-derived extracellular vesicles remodel the immune-repair microenvironment in osteoarthritis: from pathological signal transmission to regenerative therapy. · Frontiers in immunology · 2026

“EVs are membrane-bound particles actively released by cells. They can protect and deliver proteins, lipids, messenger RNA (mRNA), microRNA (miRNA), long non-coding RNA (lncRNA), circular RNA (circRNA), and metabolites in the extracellular environment”

Does not settle: Источник не устанавливает связь между кишечником и сосудистой тканью, перенос окисленных липидов, железозависимое окисление в принимающих клетках, порог самоподдержания цепи или эффект краткого подавления перекисного окисления липидов.

S8Partly answers it

Serum lipidome remodeling in viral pneumonia: from pathophysiology to therapeutics. · Frontiers in immunology · 2026

“Step 4: Accumulation of labile Fe 2+ (from ferritin breakdown) → Fenton reaction converts LOOH to lethal alkoxyl/peroxyl radicals. Step 5: Lipid peroxidation chain reaction → membrane pore formation → necrotic rupture of alveolar epithelial/endothelial barriers.”

Does not settle: Источник описывает этот путь при вирусной пневмонии в альвеолярных эпителиальных и эндотелиальных барьерах. Он оставляет открытыми связь между кишечником и сосудистой тканью, перенос окисленных липидов липопротеинами или мембранными частицами, воспроизводство цепи в последующих тканях, порог запуска, эффект краткого подавления перекисей, восстановление тканей и стабилизацию SPV_1.

S9Background

The zinc-nitric oxide axis in acute brain injury: Convergent oxidative-nitrative stress, peroxynitrite signaling, and therapeutic targets. · Redox biology · 2026

“These findings demonstrate that Zn 2+ and NO do not merely converge on overlapping injury pathways; rather, they interact through recursive feedback loops in which Zn 2+ promotes oxidative conditions that enhance NO toxicity, whereas NO- and ONOO − -mediated oxidative and nitrative damage liberates additional Zn 2+ from intracellular stores [ , , , ].”

Does not settle: This review discusses zinc–nitric oxide feedback in acute brain injury. It does not establish a gut-to-vascular lipid oxidation chain, transport by oxidized lipids in lipoproteins or membrane particles, iron-dependent oxidation in receiving cells, a reproduction-versus-termination threshold, or durable interruption of such a chain.

S10Background

Preventive effects and mechanisms of yam exosome-like nanoparticles on acute liver injury. · Journal of nanobiotechnology · 2026

“Notably, Yam ELNs pretreatment significantly reduced serum levels of lipopolysaccharide (LPS) and downregulated hepatic Toll-like receptor 4 (TLR4) expression, indicating preservation of intestinal barrier integrity and attenuation of endotoxin-triggered hepatic inflammation.”

Does not settle: Источник изучает связь кишечника и печени в модели острого поражения печени, а не кишечник и сосудистую ткань. Он не устанавливает самоподдерживающуюся межтканевую цепь окисления липидов, перенос окисленных липидов липопротеинами или мембранными частицами, железозависимое окисление в принимающих клетках, порог воспроизводства цепи или её прекращение кратким подавлением липидных перекисей.

The gap this hypothesis explains

Nothing is known here: the question has not been asked of this system.

Can breaking one link cross a damage and restore aging tissues, beyond simply reducing daily harm?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Существует ли у стареющего организма , пересечение которого воздействием на одно звено вызывает устойчивое восстановление, и как отделит этот механизм от общей суточной нагрузки?

What this question is asking

The question asks whether damage passing between tissues can become self-sustaining, and whether interrupting one causal link can switch an aging organism back toward lasting recovery. It assumes that interacting processes form a complete feedback loop, in which damage eventually feeds back to reinforce its own cause; the supplied material does not establish that full loop. The proposed signs of recovery are shrinking repeated peaks of damage, restoration of a protective tissue barrier within the first day, and a delay between responses in different systems that stays within specified limits across successive daily cycles. The decisive distinction is whether recovery follows from stopping the loop from sustaining itself or simply from reducing the total harmful burden each day. The supplied material names linked-organ and timing measurements as available tools, but does not describe their validation, the relevant barrier, or the acceptable timing limits.

What the terms mean
Self-sustaining damage
Damage whose consequences generate enough further damage to keep the process operating. The question asks whether this happens between tissues, rather than merely whether injury persists while an external harmful exposure continues.
Feedback loop or positive feedback
A chain of effects that returns to influence its starting point; positive feedback reinforces the initial change. A connection from one tissue to another establishes only part of a loop unless a returning influence is also established.
Causal link
A connection in which changing one process changes a downstream process. The proposed intervention targets one such connection within the claimed damage loop.
Damage threshold or tipping point
A boundary between different patterns of behavior, here damage that fades and damage that maintains itself. The supplied question proposes such a boundary but gives no established value or measurement for it.
Daily harmful burden
The total harm imposed over a day, as invoked by the question. The supplied material does not specify its components or how they would be combined into a measurement.
Tissue barrier and gut barrier
A layer of cells that controls movement between compartments, such as between the gut’s contents and the rest of the body. Barrier function varies in degree; a leaky gut means impaired control, rather than necessarily a complete physical break.
Delay between system responses
The elapsed time between a change in one biological system and a corresponding change in another. The question treats stable timing over daily cycles as a recovery criterion but does not provide acceptable limits.
Linked-organ and timing measurements
Tools that the supplied gap description says can investigate connections between organ systems and the timing of their responses. Their construction, capabilities, and validation are not supplied.
Liver scarring
Accumulation of scar tissue in the liver, also called hepatic fibrosis. S2 describes interacting injury processes that promote it, which provides a narrower example of self-amplifying damage.
Inflammation
A biological response to injury or threat that can also contribute to damage when it persists or becomes excessive. The sources discuss it in several settings, which do not automatically establish the same mechanism.
Regulated cell death
Cell death carried out through an organized biological process. S3 concerns a enabling such a process within cells, not a demonstrated recovery between tissues.
Macrophages
Immune cells involved in responding to injury and clearing material. They are the cellular setting identified in the supplied summary of S3.
Atrial fibrillation
An irregular heart rhythm involving the heart’s upper chambers. Susceptibility to this rhythm is the outcome reported in S5, rather than a measurement of overall recovery from aging.
Signaling component
A molecule or biological process that helps transmit an effect within or between cells. S5 reports benefits from blocking particular components of the gut–heart connection.
Cellular senescence
A cell state commonly characterized by a lasting halt in division and changes in cell function. It is not synonymous with aging of an entire organism; S7 concerns this state in the intestine.
Polystyrene particles
Small pieces of a type of plastic. Their exposure, together with particular dietary conditions, defines the injury setting described in S7.
Microorganism communities
Groups of microscopic organisms living in a particular environment, including within or on the body. S6 discusses how aging-related changes in these communities connect with bodily dysfunction.
Coronavirus disease 2019
The infectious disease discussed in S8. Its reported progression provides a different disease context for barrier failure and multiple-organ dysfunction.
Lactylation
A chemical modification of proteins. S9 discusses its inhibition as a way of suppressing a reinforcing pathway associated with brain inflammation.
Microglia
Immune cells in the brain. Excessive activation of these cells is part of the inflammation mechanism described in S9.
Alzheimer’s disease model
A research system representing selected features of a disease that damages brain function. Findings in that model do not by themselves establish effects throughout an aging organism.
What the question takes for granted
Premise only partly supported
Interacting damage processes in an aging organism form a complete, self-amplifying loop between tissues that can be distinguished from the total daily harmful burden; linked-organ and timing measurements already provide tools for investigating it.

The assumption is that injury can pass between tissues and return to worsen the injury that started the sequence. A protective tissue barrier is one proposed part of this sequence, while the time between responses in different systems is a proposed measurement of their connection. If this assumption held, improvement after interrupting one connection could potentially be interpreted as a change in the cycle itself, rather than only as less harm entering the system.

The read sources support narrower elements: S2 describes a self-amplifying network in chronic liver injury, S5 reports that interventions affecting the gut–heart connection reduce susceptibility to an abnormal heart rhythm in mice, and S9 reports suppression of a reinforcing process within a brain-disease model. These do not establish a complete self-sustaining loop between tissues in an aging organism. S4 explicitly presents the mechanism as a hypothesis. None of the supplied excerpts validates the named measurement tools or establishes a way to separate loop interruption from reduced daily harmful burden.S2S4S5S9

The same question asked without the part nothing read establishes:

  • Does interrupting one causal connection between tissues in an aging organism produce lasting recovery through a damage , beyond the effect of reducing total daily harm?
  • Do connected tissues in an aging organism continue to reinforce one another’s damage after the initiating harmful burden subsides?
What turns on the answer
  • A permits lasting recovery If interrupting one link reduces reinforcement below the level needed to sustain damage, each successive round of damage would weaken. Recovery across connected tissues would then reflect a change in the feedback process, provided that reduced daily harm alone does not explain it.
  • Improvement reflects reduced daily harm If the intervention reduces the harmful burden without changing a self-sustaining process, less damage could occur while that reduction continues. The improvement would not establish that a was crossed or that recovery would persist when the burden returned.
  • One interrupted link does not restore the system If damage continues to sustain itself despite interruption of the chosen link, improvement in one tissue would not establish recovery across the connected tissues. That outcome would leave the proposed single-link route to lasting recovery unestablished, without by itself ruling out every possible damage .
Why it matters

Under the proposed mechanism, damage in one tissue affects another, and a returning effect reinforces damage in the first tissue. If that reinforcement can maintain damage, reducing an initiating harmful exposure might leave the cycle operating. Interrupting an essential link could then allow damage to subside across the connected tissues, but lasting recovery is a further claim that needs its own evidence. Mistaking a temporary reduction in daily harm for this transition would turn a limited improvement into an unsupported claim that the organism had entered a durable recovery state.

What is already established

RL-1 и RL-2 позволяют исследовать связи, но не установлен.

What would have to be true

Повторные пики повреждения затухают; восстанавливается в первые сутки, остаётся в заданных пределах при последовательных суточных циклах.

What is missing

Отсутствует экспериментально установленный переход между затухающим и самоподдерживающимся повреждением, управляемый одним причинным звеном.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

Самоподдерживающееся повреждение возникает, когда начинает воспроизводить повреждающий химический импульс в каждой следующей ткани. Предполагаемый переносчик между кишечным и сосудистым звеньями представляет собой достаточно долгоживущие в составе или . В принимающих клетках они запускают новое и образование следующей переносчиков. определяется превышением скорости воспроизводства цепи над её обрывом и обезвреживанием продуктов. Краткое подавление образования в одном звене может погасить циркулирующую цепь; после её прекращения обычные нагрузки остаются ниже . Это стабилизирует и позволяет и восстанавливаться одновременно.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

каждого тканевого звена показывает последовательное образование новых сначала в принимающей ткани, затем в исходной после возврата . регенерируется при , превышая остаточную первоначального материала с учётом его . Она сохраняется при и отсутствии , но прекращается после в . на время исчезновения этой обеспечивает устойчивое восстановление после повторного соединения. Если эффект требует или переносится при удалённых , гипотеза отвергается.

Would tell it apart from at least one rival. The prediction specifies observable comparisons, conditions for persistence and disappearance of activity, recovery, and explicit rejection conditions. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

Доступны , изотопное прослеживание, фракционирование и независимые способы подавления . Нужно подтвердить химический состав фракции и отличить образование новых продуктов от переноса остатков первичного стимула. Опыты проводят при физиологически обоснованных концентрациях, поскольку искусственное обеднение само способно создавать условия для распространения .

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

каждого тканевого звена показывает последовательное образование новых сначала в принимающей ткани, затем в исходной после возврата . регенерируется при , превышая остаточную первоначального материала с учётом его . Она сохраняется при и отсутствии , но прекращается после в . на время исчезновения этой обеспечивает устойчивое восстановление после повторного соединения. Если эффект требует или переносится при удалённых , гипотеза отвергается.

  • What would separate them

    Repair-driven cell division may sustain a cycle of damage between the gut and blood vessels predicts: В связанной модели кишечника и после удаления исходного повреждающего стимула новые очаги повреждения преимущественно возникают в потомках клеток, вступивших в деление после первичного эпизода. Обратимая остановка клеточного цикла только в принимающего звена на один цикл восстановления прекращает последующие волны в обеих тканях. Эффект сохраняется после возобновления деления и при прежней суточной нагрузке. Численность первоначальных при этом может оставаться прежней. Если повреждение продолжает распространяться при подтверждённой , а прекращается при подавлении или образования , гипотеза отвергается в пользу соответствующего соперника.

  • What would separate them

    Selection against repair-contributing stromal cells may sustain damage across tissues predicts: При одинаковых общей численности клеток, начальном повреждении и суточной нагрузке исходная доля определяет противоположные долгосрочные траектории. Ниже независимо оценённого эта доля уменьшается, выше него возрастает; вслед за этим соответственно усиливаются или затухают повторные повреждения. Краткое вмешательство даёт устойчивый результат только при пересечении состава. Одинаковое временное торможение деления обеих , сохраняющее их соотношение, устойчивого переключения не вызывает. При экспериментально постоянном составе клеток предполагаемый переход исчезает, даже если продолжается.

  • What would separate them

    Calcium phosphate particle growth may sustain damage between the gut and blood vessels predicts: При одинаковых , , белковом составе и внешних нагрузках малая добавка охарактеризованных запускает длительное образование новых частиц и повторные пики повреждения. Частицы с подавленной способностью к росту при сопоставимых размере и такого эффекта не дают. Избирательное растворение прекращает передачу повреждения после восстановления исходных концентраций . Добавление новых вновь запускает цикл после отмены вмешательства. Зависимость от сохраняется при подавлении деления клеток; при сохранённой минеральной одно устранение устойчивого выключения не обеспечивает.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionWould tell it apart from at least one rivalTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.